Gene Editing Therapeutics Market Report 2024, Featuring Profiles of Key Players Allogene Therapeutics, CRISPR Therapeutics, Intellia Therapeutics, Sangamo Therapeutics and Vertex Pharmaceuticals - ResearchAndMarkets.com

BusinesswireSep 16 10:10 ET

CRISPR Therapeutics AG (CRSP): Among the Worst ARK Stocks According to Short Sellers

Yahoo FinanceSep 8 16:51 ET

CRISPR Therapeutics AG (NASDAQ:CRSP) Investors Are Less Pessimistic Than Expected

Simply Wall StSep 4 12:24 ET

Why Is CRISPR Therapeutics (CRSP) Down 7.7% Since Last Earnings Report?

Yahoo FinanceSep 4 11:30 ET

Express News | CRISPR Therapeutics AG : Truist Securities Cuts Target Price to $100 From $120

ReutersAug 12 07:18 ET

Truist Adjusts Price Target on CRISPR Therapeutics to $100 From $120, Maintains Buy Rating

MT NewswiresAug 12 06:10 ET · Ratings